Skip to main content
Top
Published in: Reactions Weekly 1/2024

01-04-2024 | Dexamethasone | Case report

Dexamethasone/Lenalidomide

Anaemia, myalgia and lack of efficacy

Published in: Reactions Weekly | Issue 1/2024

Login to get access

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literature
go back to reference Uppuluri R, et al. Prospective collaborative study for pulse dexamethasone and lenalidomide in relapsed / refractory langerhans cell histiocytosis (LENDEX-LCH study): INPHOG-HIST-19-03 (CTRI/2020/07/026937). Pediatric Hematology Oncology Journal 8 (Suppl.): S11-S12, No. 4, Jan 2023. Available from: URL: https://dx.doi.org/10.1016/j.phoj.2023.10.006 Uppuluri R, et al. Prospective collaborative study for pulse dexamethasone and lenalidomide in relapsed / refractory langerhans cell histiocytosis (LENDEX-LCH study): INPHOG-HIST-19-03 (CTRI/2020/07/026937). Pediatric Hematology Oncology Journal 8 (Suppl.): S11-S12, No. 4, Jan 2023. Available from: URL: https://​dx.​doi.​org/​10.​1016/​j.​phoj.​2023.​10.​006
Metadata
Title
Dexamethasone/Lenalidomide
Anaemia, myalgia and lack of efficacy
Publication date
01-04-2024
Publisher
Springer International Publishing
Published in
Reactions Weekly / Issue 1/2024
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-024-56160-0

Other articles of this Issue 1/2024

Reactions Weekly 1/2024 Go to the issue